SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-008161
Filing Date
2021-08-05
Accepted
2021-08-05 17:07:04
Documents
16
Period of Report
2021-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_073021.htm   iXBRL 8-K 48829
2 ASSET PURCHASE AGREEMENT ex2-1.htm EX-2.1 76086
3 SUPPLY AGREEMENT ADDENDUM ex10-1.htm EX-10.1 53084
4 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ex99-1.htm EX-99.1 185022
5 PRESS RELEASE ex99-2.htm EX-99.2 8966
  Complete submission text file 0001387131-21-008161.txt   603459

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20210730.xsd EX-101.SCH 3063
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20210730_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20210730_pre.xml EX-101.PRE 22384
9 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_073021_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 211149369
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences